Progress x 2 ? Just as suggested would happen, the 50

New Post Public Reply Private Reply Replies (0) Message Board
joey68
Progress x 2 ?

Just as suggested would happen, the 50 and 200MA lines have not only creeped closer today; they creeped closer by two. As of this post, they are only .0036 away from a Golden Cross. I see .002's on the horizon; possibly before the 10Q. Who knows, I could be wrong. Maybe they'll grow further apart.

Remember, many investors out there don't know SCIE exists. Many of these investors are serious / professional investors who use stock scanners which alert them when an unknown stock forms a Golden Cross. If we can just get to this long-term indicator, I believe volume will slowly being to build as silent investors start building positions. Not only that, but I continue to find it interesting that the chart may form a Golden Cross around the time of the 10Q.
Not only that (again), but many serious investors don't invest under .10, .25, and .50 cents. Being notified of a Golden Cross may entice them to keep SCIE on their radar.

Random Ramblings (RR):

SCIE is probably one of my most serious investments. I consider this as a 'No play time' stock meaning, once the share price hits my sell limit order, I'm out (I may keep a small amount invested), no looking back, taking profits, and no crying if the stock were to skyrocket the day after selling. Another stock I'm watching went from .0028 to almost 10 cents in less than two months and is currently crashing. Who knows if it will go back up. This is why I'm not fooling around with SCIE, and this is why I believe many new investors never make a large profit, get discouraged with the market, and quit; they dont know when to sell. Learning the hard way, I'm learning to take profits from one stock and invest some of the profit in another stock. Repeat this process enough and I'll be on my way to a million+. Buy in, hold (sell if my DD/gut tells me to sell), and then sell. Of course, the reader needs to make their own investment decisions and must NOT invest based on this post.

Obviously this post is NOT investment advice; all my opinion. Do NOT invest based on this post. Go call your investment advisor about your investments.

Note
Putting on your long-term investment goggles, zoom out of the chart to a 1 year view and youll clearly notice a slight uptrend forming since April 27, 2016. This isn't to say SCIE cant go down, but as of this post, it is clearly occurring.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aurzen Leverages Basquiat for Art-Infused Projection Line

Updated Category News Views 2

A Fresh Perspective on Portable Projection If anyone had told me a tech brand would buddy up with the world of fine art to launch a new gadget line, I'd have raised an eyebrow. But here we are, shrugging away the standard and looking at what's cooking over at Aurzen. The company's new initiative, 'Unfold the Art,' marries the magnetism of Jean-Michel Basquiat's artwork...

Continue Reading
PinkBlush Maternity Unveils Its 2026 Fall Fashion Line

Updated Category News Views 2

Elevating Maternity Fashion with PinkBlush's Fall 2026 Line You know, it's not every day you see maternitywear aiming to push the envelope, but that's exactly what PinkBlush is doing this fall. They've unleashed their Fall 2026 collection, and let's just say, it's less about the frills and more about redefining what expecting mothers can expect from the fashion world. A...

Continue Reading
Lennar Unveils Lake Martin Community Homes

Updated Category News Views 3

Lake Martin's New Residential Offering Step aside, beaches and mountains. Now it's all about lakeside living with some good old Alabama charm. Lennar, a heavyweight in the homebuilding scene, is opening the gates to The Oaks at Eclectic—a fresh batch of single-family homes sprouting near Lake Martin in Eclectic, Alabama. This spot is practically a haven for those who...

Continue Reading
Lupin Gains FDA Nod for Modafinil, Eyes US Market

Updated Category News Views 1

In the ever-evolving landscape of pharmaceuticals, Lupin Limited's recent triumph snagging FDA approval for their Modafinil Tablets was a move you couldn't miss even if you'd tried. While the rooms of Mumbai and boardrooms around the globe might have been abuzz, investors should tune in to the humming potential of this development—especially if they're navigating the...

Continue Reading
AI Data Retention: FastGPT’s Detailed Deletion Protocols

Updated Category News Views 3

In the world of AI-driven applications, data retention has become a hot potato, especially when we're talking about sensitive information like conversation records and audit logs. FastGPT, an open-source AI platform, has decided to tell it like it is by detailing exactly how these data pieces are retained and ultimately booted out. All this info was scattered to the winds...

Continue Reading
CreditRefresh's AI Tackles 1,000+ Disputes Launch Month

Updated Category News Views 3

AI-Powered Revolution in Credit Disputes Alright, here we are staring down the latest twist in the credit game. CreditRefresh, an AI-driven platform out of Dover, Delaware, has managed to kickstart its journey by challenging over 1,000 credit report errors in just its first month on the market. That's quite a sprint straight from the gate, don't you think? But hey, this...

Continue Reading
TriStar Bank Community Room: A Space for Growth

Updated Category News Views 1

Building Bridges Through Community Investment Well, ain't this something? Columbia, Tennessee, just got a splash of fresh air. We're talking about the new Southern Regional Technology Center nested in Columbia State Community College. Now, the name on everyone's lips? The TriStar Bank Community Room. But it ain't just about a name plastered up on a wall inside a shiny...

Continue Reading
Fujifilm's New 400mm Lens: A Game Changer?

Updated Category News Views 1

Big Moves from Fujifilm's Camp Now we're talking, Fujifilm! Just when you think they might ease off the throttle, they crank up the heat with the XF 400mm f/4.5 R LM OIS WR lens. This isn’t just your run-of-the-mill update. It's a significant addition to their already beefed-up lineup for sports and wildlife. You know what that means: more reach, less baggage. Compact...

Continue Reading
New Concierge Pediatric Care at Weill Cornell Launches

Updated Category News Views 1

A New Way Forward in Pediatric Care When a couple of seasoned pediatricians decide it's time for something fresh, eyes and ears perk up. Enter Dr. Paul W. Chung and Dr. Jane E. Rosini, diving headfirst into a revolutionary pediatric concierge program courtesy of Concierge Choice Physicians (CCP). We're talking a substantial shake-up at Weill Cornell Medicine, aiming to...

Continue Reading
Inturai Ventures Closes Final Tranche with a Twist

Updated Category News Views 2

Wrapping Up a Wild Ride in the Investment Arena Markets are a fickle friend, and today we've got Inturai Ventures calling it a day on their latest cash grab. They've locked the final tranche of their private placement, pulling in an aggregate $963,713.70. Feels like they're counting pennies in this venture, but every cent counts when your aim is to shake up industries...

Continue Reading

Top 5 Most Recently Viewed Articles

Canadian Life Companies Split Corp. Announces Share Dividend

Updated Category News Views 121

Canadian Life Companies Split Corp. Dividend Announcement Canadian Life Companies Split Corp. is excited to announce the declaration of its monthly dividend distributions. For each Class A share, the corporation will distribute $0.10000, and for each Preferred share, a distribution of $0.05833 has been set. These distributions will be payable on November 10, 2025, to...

Continue Reading
Quantum Corp. Class Action Lawsuit: What Investors Need to Know

Updated Category News Views 185

Understanding the Quantum Corp. Lawsuit Recently, a class action lawsuit was initiated against Quantum Corporation, also known as Quantum Corp. This development stems from accusations regarding the company's financial reporting practices. The lawsuit suggests that the company may have incorrectly accounted for its revenue during the financial period that concluded in...

Continue Reading
Capricor Therapeutics: Key Deadlines for Shareholders to Remember

Updated Category News Views 129

Crucial Dates for Capricor Therapeutics Shareholders The Gross Law Firm has released an important notice for shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR). The firm encourages anyone who purchased shares during the specified class period to connect with them regarding possible lead plaintiff appointments. Being appointed as the lead plaintiff isn't necessary...

Continue Reading
Voting Rights Update: Key Figures and Company Overview

Updated Category News Views 110

Understanding KBC Ancora's Voting Rights KBC Ancora periodically updates its shareholders on the total number of voting rights associated with its shares. As part of its compliance with the regulatory framework, specifically the Article 15 of the Act of 2 May 2007, KBC Ancora shares information about its capital, voting shares, and rights that might influence shareholder...

Continue Reading
Brenmiller Energy's Thermal Storage Boosts Clean Energy in Spain

Updated Category News Views 105

Brenmiller Energy's Innovative Partnership for a Greener Future Brenmiller Energy Ltd. (Nasdaq: BNRG) has made a significant stride in the world of clean energy with the announcement of their bGen™ ZERO thermal energy storage system being selected for an ambitious project led by Resources of Biomass (REBI), a prominent Energy Service Company in Spain. This collaboration...

Continue Reading